Zulresso (Brexanalone)

What Is Zulresso (Brexanalone)?

Zulresso (Brexanalone) is a novel IV (intravenous) treatment approved by the FDA for the treatment of postpartum depression in adult women. PPD is a major depressive episode that most often occurs following childbirth, though can sometimes start during pregnancy, characterized by sadness, loss of interest in usual activities, and difficulty finding pleasure in life or forming emotional connections with others.